Journal of Personalized Medicine Receives an Increased CiteScore of 4.1

We are pleased to inform you that Journal of Personalized Medicine (JPM, ISSN: 2075-4426) has received an increased CiteScore of 4.1.

CiteScore provides transparent metrics that enable well-informed publishing strategy, library collection development, and the benchmarking of journal performance. It is now a standard citation metric alongside SNIP and SJR that gives an up-to-date view of a journal’s impact.

The 2023 CiteScore provides an assessment of the scientific influence of journals in the 2020 to 2023 period.

This is a reflection of the excellent performance, support, and dedication of all journal editors, reviewers, authors, and readers.

JPM’s CiteScore ranks as follows:

• Q2 (137 out of 398) in the “ Medicine (miscellaneous)” category.

For more journal statistics, please visit https://www.mdpi.com/journal/jpm/stats.

Thank you to everyone who has contributed to the journal.

JPM Editorial Office